Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 22
Filter
1.
Neuroimage ; 51(2): 623-8, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20156571

ABSTRACT

Echo planar imaging (EPI), the gold standard technique for functional MRI (fMRI), is based on fast magnetic field gradient switching. These time-varying magnetic fields induce electric (E) fields in the brain that could influence neuronal activity; but this has not been tested. Here we assessed the effects of EPI on brain glucose metabolism (marker of brain function) using PET and 18F 2-fluoro-2-deoxy-D-glucose ((18)FDG). Fifteen healthy subjects were in a 4 T magnet during the (18)FDG uptake period twice: with (ON) and without (OFF) EPI gradients pulses along the z-axis (G(z): 23 mT/m; 250 mus rise-time; 920 Hz). The E-field from these EPI pulses is non-homogeneous, increasing linearly from the gradient's isocenter (radial and z directions), which allowed us to assess the correlation between local strength of the E-field and the regional metabolic differences between ON and OFF sessions. Metabolic images were normalized to metabolic activity in the plane positioned at the gradient's isocenter where E=0 for both ON and OFF conditions. Statistical parametric analyses used to identify regions that differed between ON versus OFF (p<0.05, corrected) showed that the relative metabolism was lower in areas at the poles of the brain (inferior occipital and frontal and superior parietal cortices) for ON than for OFF, which was also documented with individual region of interest analysis. Moreover the magnitude of the metabolic decrements was significantly correlated with the estimated strength of E (r=0.68, p<0.0001); the stronger the E-field the larger the decreases. However, we did not detect differences between ON versus OFF conditions on mood ratings nor on absolute whole brain metabolism. This data provides preliminary evidence that EPI sequences may affect neuronal activity and merits further investigation.


Subject(s)
Brain Mapping , Brain/metabolism , Glucose/metabolism , Magnetic Resonance Imaging/methods , Magnetics , Adult , Affect , Brain/diagnostic imaging , Fluorodeoxyglucose F18 , Humans , Image Interpretation, Computer-Assisted , Male , Positron-Emission Tomography , Radiopharmaceuticals
2.
Neuroimage ; 49(3): 2536-43, 2010 Feb 01.
Article in English | MEDLINE | ID: mdl-19913102

ABSTRACT

Loss of control over drug taking is considered a hallmark of addiction and is critical in relapse. Dysfunction of frontal brain regions involved with inhibitory control may underlie this behavior. We evaluated whether addicted subjects when instructed to purposefully control their craving responses to drug-conditioned stimuli can inhibit limbic brain regions implicated in drug craving. We used PET and 2-deoxy-2[18F]fluoro-d-glucose to measure brain glucose metabolism (marker of brain function) in 24 cocaine abusers who watched a cocaine-cue video and compared brain activation with and without instructions to cognitively inhibit craving. A third scan was obtained at baseline (without video). Statistical parametric mapping was used for analysis and corroborated with regions of interest. The cocaine-cue video increased craving during the no-inhibition condition (pre 3+/-3, post 6+/-3; p<0.001) but not when subjects were instructed to inhibit craving (pre 3+/-2, post 3+/-3). Comparisons with baseline showed visual activation for both cocaine-cue conditions and limbic inhibition (accumbens, orbitofrontal, insula, cingulate) when subjects purposefully inhibited craving (p<0.001). Comparison between cocaine-cue conditions showed lower metabolism with cognitive inhibition in right orbitofrontal cortex and right accumbens (p<0.005), which was associated with right inferior frontal activation (r=-0.62, p<0.005). Decreases in metabolism in brain regions that process the predictive (nucleus accumbens) and motivational value (orbitofrontal cortex) of drug-conditioned stimuli were elicited by instruction to inhibit cue-induced craving. This suggests that cocaine abusers may retain some ability to inhibit craving and that strengthening fronto-accumbal regulation may be therapeutically beneficial in addiction.


Subject(s)
Brain Mapping , Brain/diagnostic imaging , Cocaine-Related Disorders/diagnostic imaging , Reward , Brain/physiopathology , Cocaine-Related Disorders/physiopathology , Cues , Female , Fluorodeoxyglucose F18 , Humans , Image Interpretation, Computer-Assisted , Male , Middle Aged , Positron-Emission Tomography
3.
JAMA ; 302(10): 1084-91, 2009 Sep 09.
Article in English | MEDLINE | ID: mdl-19738093

ABSTRACT

CONTEXT: Attention-deficit/hyperactivity disorder (ADHD)--characterized by symptoms of inattention and hyperactivity-impulsivity--is the most prevalent childhood psychiatric disorder that frequently persists into adulthood, and there is increasing evidence of reward-motivation deficits in this disorder. OBJECTIVE: To evaluate biological bases that might underlie a reward/motivation deficit by imaging key components of the brain dopamine reward pathway (mesoaccumbens). DESIGN, SETTING, AND PARTICIPANTS: We used positron emission tomography to measure dopamine synaptic markers (transporters and D(2)/D(3) receptors) in 53 nonmedicated adults with ADHD and 44 healthy controls between 2001-2009 at Brookhaven National Laboratory. MAIN OUTCOME MEASURES: We measured specific binding of positron emission tomographic radioligands for dopamine transporters (DAT) using [(11)C]cocaine and for D(2)/D(3) receptors using [(11)C]raclopride, quantified as binding potential (distribution volume ratio -1). RESULTS: For both ligands, statistical parametric mapping showed that specific binding was lower in ADHD than in controls (threshold for significance set at P < .005) in regions of the dopamine reward pathway in the left side of the brain. Region-of-interest analyses corroborated these findings. The mean (95% confidence interval [CI] of mean difference) for DAT in the nucleus accumbens for controls was 0.71 vs 0.63 for those with ADHD (95% CI, 0.03-0.13, P = .004) and in the midbrain for controls was 0.16 vs 0.09 for those with ADHD (95% CI, 0.03-0.12; P < or = .001); for D(2)/D(3) receptors, the mean accumbens for controls was 2.85 vs 2.68 for those with ADHD (95% CI, 0.06-0.30, P = .004); and in the midbrain, it was for controls 0.28 vs 0.18 for those with ADHD (95% CI, 0.02-0.17, P = .01). The analysis also corroborated differences in the left caudate: the mean DAT for controls was 0.66 vs 0.53 for those with ADHD (95% CI, 0.04-0.22; P = .003) and the mean D(2)/D(3) for controls was 2.80 vs 2.47 for those with ADHD (95% CI, 0.10-0.56; P = .005) and differences in D(2)/D(3) in the hypothalamic region, with controls having a mean of 0.12 vs 0.05 for those with ADHD (95% CI, 0.02-0.12; P = .004). Ratings of attention correlated with D(2)/D(3) in the accumbens (r = 0.35; 95% CI, 0.15-0.52; P = .001), midbrain (r = 0.35; 95% CI, 0.14-0.52; P = .001), caudate (r = 0.32; 95% CI, 0.11-0.50; P = .003), and hypothalamic (r = 0.31; CI, 0.10-0.49; P = .003) regions and with DAT in the midbrain (r = 0.37; 95% CI, 0.16-0.53; P < or = .001). CONCLUSION: A reduction in dopamine synaptic markers associated with symptoms of inattention was shown in the dopamine reward pathway of participants with ADHD.


Subject(s)
Attention Deficit Disorder with Hyperactivity/physiopathology , Brain/diagnostic imaging , Brain/metabolism , Dopamine Plasma Membrane Transport Proteins/metabolism , Dopamine/physiology , Receptors, Dopamine D2/metabolism , Adult , Attention Deficit Disorder with Hyperactivity/diagnostic imaging , Attention Deficit Disorder with Hyperactivity/psychology , Brain Mapping , Carbon Radioisotopes , Cocaine , Dopamine Agents , Female , Humans , Male , Mesencephalon/diagnostic imaging , Mesencephalon/metabolism , Positron-Emission Tomography , Raclopride , Reward , Synaptic Transmission
4.
Proc Natl Acad Sci U S A ; 106(4): 1249-54, 2009 Jan 27.
Article in English | MEDLINE | ID: mdl-19164587

ABSTRACT

Although impaired inhibitory control is linked to a broad spectrum of health problems, including obesity, the brain mechanism(s) underlying voluntary control of hunger are not well understood. We assessed the brain circuits involved in voluntary inhibition of hunger during food stimulation in 23 fasted men and women using PET and 2-deoxy-2[(18)F]fluoro-D-glucose ((18)FDG). In men, but not in women, food stimulation with inhibition significantly decreased activation in amygdala, hippocampus, insula, orbitofrontal cortex, and striatum, which are regions involved in emotional regulation, conditioning, and motivation. The suppressed activation of the orbitofrontal cortex with inhibition in men was associated with decreases in self-reports of hunger, which corroborates the involvement of this region in processing the conscious awareness of the drive to eat. This finding suggests a mechanism by which cognitive inhibition decreases the desire for food and implicates lower ability to suppress hunger in women as a contributing factor to gender differences in obesity.


Subject(s)
Brain Mapping , Food , Sex Characteristics , Adult , Cognition , Female , Humans , Male , Middle Aged , Physical Stimulation , Positron-Emission Tomography , Regression Analysis , Stereotaxic Techniques , Surveys and Questionnaires
5.
Neuroimage ; 43(4): 756-63, 2008 Dec.
Article in English | MEDLINE | ID: mdl-18708148

ABSTRACT

Methamphetamine is one of the most addictive and neurotoxic drugs of abuse. It produces large elevations in extracellular dopamine in the striatum through vesicular release and inhibition of the dopamine transporter. In the U.S. abuse prevalence varies by ethnicity with very low abuse among African Americans relative to Caucasians, differentiating it from cocaine where abuse rates are similar for the two groups. Here we report the first comparison of methamphetamine and cocaine pharmacokinetics in brain between Caucasians and African Americans along with the measurement of dopamine transporter availability in striatum. Methamphetamine's uptake in brain was fast (peak uptake at 9 min) with accumulation in cortical and subcortical brain regions and in white matter. Its clearance from brain was slow (except for white matter which did not clear over the 90 min) and there was no difference in pharmacokinetics between Caucasians and African Americans. In contrast cocaine's brain uptake and clearance were both fast, distribution was predominantly in striatum and uptake was higher in African Americans. Among individuals, those with the highest striatal (but not cerebellar) methamphetamine accumulation also had the highest dopamine transporter availability suggesting a relationship between METH exposure and DAT availability. Methamphetamine's fast brain uptake is consistent with its highly reinforcing effects, its slow clearance with its long-lasting behavioral effects and its widespread distribution with its neurotoxic effects that affect not only striatal but also cortical and white matter regions. The absence of significant differences between Caucasians and African Americans suggests that variables other than methamphetamine pharmacokinetics and bioavailability account for the lower abuse prevalence in African Americans.


Subject(s)
Black or African American , Brain/metabolism , Cocaine/pharmacokinetics , Methamphetamine/pharmacokinetics , Positron-Emission Tomography/methods , White People , Adult , Brain/diagnostic imaging , Carbon Radioisotopes/administration & dosage , Carbon Radioisotopes/pharmacokinetics , Cocaine/administration & dosage , Humans , Male , Metabolic Clearance Rate , Methamphetamine/administration & dosage , Middle Aged , Tissue Distribution , Young Adult
6.
Neuroimage ; 42(4): 1537-43, 2008 Oct 01.
Article in English | MEDLINE | ID: mdl-18598772

ABSTRACT

Dopamine's role in inhibitory control is well recognized and its disruption may contribute to behavioral disorders of discontrol such as obesity. However, the mechanism by which impaired dopamine neurotransmission interferes with inhibitory control is poorly understood. We had previously documented a reduction in dopamine D2 receptors in morbidly obese subjects. To assess if the reductions in dopamine D2 receptors were associated with activity in prefrontal brain regions implicated in inhibitory control we assessed the relationship between dopamine D2 receptor availability in striatum with brain glucose metabolism (marker of brain function) in ten morbidly obese subjects (BMI>40 kg/m(2)) and compared it to that in twelve non-obese controls. PET was used with [(11)C]raclopride to assess D2 receptors and with [(18)F]FDG to assess regional brain glucose metabolism. In obese subjects striatal D2 receptor availability was lower than controls and was positively correlated with metabolism in dorsolateral prefrontal, medial orbitofrontal, anterior cingulate gyrus and somatosensory cortices. In controls correlations with prefrontal metabolism were not significant but comparisons with those in obese subjects were not significant, which does not permit to ascribe the associations as unique to obesity. The associations between striatal D2 receptors and prefrontal metabolism in obese subjects suggest that decreases in striatal D2 receptors could contribute to overeating via their modulation of striatal prefrontal pathways, which participate in inhibitory control and salience attribution. The association between striatal D2 receptors and metabolism in somatosensory cortices (regions that process palatability) could underlie one of the mechanisms through which dopamine regulates the reinforcing properties of food.


Subject(s)
Corpus Striatum/metabolism , Obesity, Morbid/metabolism , Prefrontal Cortex/metabolism , Receptors, Dopamine D2/metabolism , Corpus Striatum/diagnostic imaging , Down-Regulation , Female , Humans , Male , Middle Aged , Obesity, Morbid/diagnostic imaging , Positron-Emission Tomography/methods , Prefrontal Cortex/diagnostic imaging
7.
Psychiatry Res ; 162(3): 205-13, 2008 Apr 15.
Article in English | MEDLINE | ID: mdl-18280711

ABSTRACT

Acute alcohol administration decreases overall brain glucose metabolism, which serves as a marker of brain activity. The behavioral effects of alcohol, however, are likely to reflect not only changes in regional brain activity but also the patterns of brain functional organization. Here we assessed the effects of a moderate dose of alcohol on the patterns of brain activity and cerebral differentiation. We measured brain glucose metabolism in 20 healthy controls with positron emission tomography and fluorodeoxyglucose during baseline and during alcohol intoxication (0.75 g/kg). We used the coefficient of variation (CV) to assess changes in brain metabolic homogeneity, which we used as a marker for cerebral differentiation. We found that alcohol decreased the CV in the brain and this effect was independent of the decrements in overall glucose metabolism. Our study revealed marked disruption in brain activity during alcohol intoxication including decreases in global and regional brain differentiation, a loss of right versus left brain metabolic laterality and a shift in the predominance of activity from cortical to limbic brain regions. The widespread nature of the changes induced by a moderate dose of alcohol is likely to contribute to the marked disruption of alcohol on behavior, mood, cognition and motor activity.


Subject(s)
Brain/drug effects , Brain/metabolism , Central Nervous System Depressants/adverse effects , Ethanol/adverse effects , Adult , Alcoholic Intoxication/diagnostic imaging , Alcoholic Intoxication/metabolism , Brain/diagnostic imaging , Central Nervous System Depressants/administration & dosage , Dose-Response Relationship, Drug , Ethanol/administration & dosage , Female , Functional Laterality/drug effects , Glucose/administration & dosage , Glucose/pharmacokinetics , Humans , Male , Middle Aged , Positron-Emission Tomography
8.
Neuroimage ; 39(3): 1266-73, 2008 Feb 01.
Article in English | MEDLINE | ID: mdl-18024160

ABSTRACT

Imaging studies have shown an association between dopamine increases in striatum and cue induced craving in cocaine abusers. However, the extent to which dopamine increases reflect a primary rather than a secondary response to the cues remains unclear. Here we evaluated the extent to which dopamine increases by themselves can induce craving in cocaine abusers. Using PET and [(11)C]raclopride (D2 receptor radioligand sensitive to competition with endogenous dopamine) we show that in cocaine abusers (n=20) oral methylphenidate (20 mg), which significantly increased dopamine in striatum, did not induce craving unless subjects were concomitantly exposed to cocaine cues (video scenes of subjects self-administering cocaine). This suggests that dopamine increases associated with conditioned cues are not primary responses but reflect downstream stimulation of dopamine cells (presumably glutamatergic afferents from prefrontal cortex and/or amygdala). Inasmuch as afferent stimulation of dopamine neurons results in phasic cell firing these findings suggest that "fast" dopamine increases, in contrast to the "slow" dopamine increases as achieved when using oral methylphenidate (mimicking tonic dopamine cell firing), are required for cues to trigger craving. The fact that methylphenidate induced craving only when given with the cocaine cues highlights the context dependency of methylphenidate's effects and suggests that its use for the treatment of ADHD subjects with co-morbid drug abuse should not increase craving.


Subject(s)
Cocaine-Related Disorders/metabolism , Cocaine-Related Disorders/psychology , Cues , Dopamine/metabolism , Neostriatum/metabolism , Adult , Blood Pressure/drug effects , Brain/anatomy & histology , Brain Chemistry/drug effects , Cocaine-Related Disorders/diagnostic imaging , Dopamine Antagonists , Dopamine Uptake Inhibitors/pharmacology , Female , Heart Rate/drug effects , Humans , Image Processing, Computer-Assisted , Male , Methylphenidate/pharmacology , Middle Aged , Neostriatum/diagnostic imaging , Positron-Emission Tomography , Raclopride , Surveys and Questionnaires , Tomography
9.
J Neurosci ; 27(46): 12700-6, 2007 Nov 14.
Article in English | MEDLINE | ID: mdl-18003850

ABSTRACT

The value of rewards (natural rewards and drugs) is associated with dopamine increases in the nucleus accumbens and varies as a function of context. The prefrontal cortex has been implicated in the context dependency of rewards and in the fixated high value that drugs have in addiction, although the mechanisms are not properly understood. Here we test the hypothesis that the prefrontal cortex regulates the value of rewards by modulating dopamine increases in nucleus accumbens and that this regulation is disrupted in addicted subjects. We used positron emission tomography to evaluate the activity of the prefrontal cortex (measuring brain glucose metabolism with [18F]fluorodeoxyglucose) and dopamine increases (measured with [11C]raclopride, a D2/D3 receptor ligand with binding that is sensitive to endogenous dopamine) induced by the stimulant drug methylphenidate in 20 controls and 20 detoxified alcoholics, most of whom smoked. In all subjects, methylphenidate significantly increased dopamine in striatum. In ventral striatum (where the nucleus accumbens is located) and in putamen, dopamine increases were associated with the rewarding effects of methylphenidate (drug liking and high) and were profoundly attenuated in alcoholics (70 and 50% lower than controls, respectively). In controls, but not in alcoholics, metabolism in orbitofrontal cortex (region involved with salience attribution) was negatively associated with methylphenidate-induced dopamine increases in ventral striatum. These results are consistent with the hypothesis that the orbitofrontal cortex modulates the value of rewards by regulating the magnitude of dopamine increases in the ventral striatum and that disruption of this regulation may underlie the decreased sensitivity to rewards in addicted subjects.


Subject(s)
Alcohol-Induced Disorders, Nervous System/metabolism , Corpus Striatum/drug effects , Dopamine/metabolism , Ethanol/adverse effects , Prefrontal Cortex/drug effects , Reward , Adult , Alcohol-Induced Disorders, Nervous System/diagnostic imaging , Alcohol-Induced Disorders, Nervous System/physiopathology , Alcoholism/diagnostic imaging , Alcoholism/metabolism , Alcoholism/physiopathology , Brain Chemistry/drug effects , Brain Chemistry/physiology , Central Nervous System Depressants/adverse effects , Corpus Striatum/metabolism , Corpus Striatum/physiopathology , Dopamine Antagonists , Dopamine Uptake Inhibitors/pharmacology , Down-Regulation/drug effects , Down-Regulation/physiology , Glucose/metabolism , Humans , Male , Methylphenidate/pharmacology , Middle Aged , Neural Pathways/drug effects , Neural Pathways/metabolism , Neural Pathways/physiopathology , Positron-Emission Tomography , Prefrontal Cortex/metabolism , Prefrontal Cortex/physiopathology , Raclopride
10.
Arch Gen Psychiatry ; 64(8): 932-40, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17679638

ABSTRACT

CONTEXT: Attention-deficit/hyperactivity disorder (ADHD) is the most prevalent psychiatric disorder of childhood. There is considerable evidence that brain dopamine is involved in ADHD, but it is unclear whether dopamine activity is enhanced or depressed. OBJECTIVE: To test the hypotheses that striatal dopamine activity is depressed in ADHD and that this contributes to symptoms of inattention. DESIGN: Clinical (ADHD adult) and comparison (healthy control) subjects were scanned with positron emission tomography and raclopride labeled with carbon 11 (D2/D3 receptor radioligand sensitive to competition with endogenous dopamine) after placebo and after intravenous methylphenidate hydrochloride (stimulant that increases extracellular dopamine by blocking dopamine transporters). The difference in [11C]raclopride's specific binding between placebo and methylphenidate was used as marker of dopamine release. Symptoms were quantified using the Conners Adult ADHD Rating Scales. SETTING: Outpatient setting. PARTICIPANTS: Nineteen adults with ADHD who had never received medication and 24 healthy controls. RESULTS: With the placebo, D2/D3 receptor availability in left caudate was lower (P < .05) in subjects with ADHD than in controls. Methylphenidate induced smaller decrements in [11C]raclopride binding in left and right caudate (blunted DA increases) (P < .05) and higher scores on self-reports of "drug liking" in ADHD than in control subjects. The blunted response to methylphenidate in caudate was associated with symptoms of inattention (P < .05) and with higher self-reports of drug liking (P < .01). Exploratory analysis using statistical parametric mapping revealed that methylphenidate also decreased [11C]raclopride binding in hippocampus and amygdala and that these decrements were smaller in subjects with ADHD (P < .001). CONCLUSIONS: This study reveals depressed dopamine activity in caudate and preliminary evidence in limbic regions in adults with ADHD that was associated with inattention and with enhanced reinforcing responses to intravenous methylphenidate. This suggests that dopamine dysfunction is involved with symptoms of inattention but may also contribute to substance abuse comorbidity in ADHD.


Subject(s)
Attention Deficit Disorder with Hyperactivity/physiopathology , Caudate Nucleus/metabolism , Dopamine/metabolism , Dopamine/physiology , Limbic System/metabolism , Adult , Attention/drug effects , Attention Deficit Disorder with Hyperactivity/diagnostic imaging , Attention Deficit Disorder with Hyperactivity/metabolism , Carbon Radioisotopes , Caudate Nucleus/diagnostic imaging , Central Nervous System Stimulants/pharmacology , Corpus Striatum/diagnostic imaging , Corpus Striatum/metabolism , Dopamine Plasma Membrane Transport Proteins/drug effects , Dopamine Plasma Membrane Transport Proteins/metabolism , Female , Functional Laterality/drug effects , Functional Laterality/physiology , Humans , Limbic System/diagnostic imaging , Male , Methylphenidate/pharmacology , Placebos , Positron-Emission Tomography , Psychiatric Status Rating Scales , Raclopride , Receptors, Dopamine/drug effects , Receptors, Dopamine/metabolism , Receptors, Dopamine/physiology
11.
Neuroimage ; 34(3): 1182-90, 2007 Feb 01.
Article in English | MEDLINE | ID: mdl-17126039

ABSTRACT

Attention deficit hyperactivity disorder (ADHD) is the most frequent psychiatric disorder in children, yet data are sparse on its pathophysiology. Particularly relevant are the dopamine transporters since these are the main targets of stimulant medications used for ADHD treatment. Though some imaging studies have shown increases in dopamine transporters in ADHD others have not and their role in the neurobiology of ADHD remains unclear. Here we investigate dopamine transporters in ADHD subjects with control of potentially confounding factors (previous medication and/or drug histories, comorbidity) and their association with clinical symptoms. Positron emission tomography and [11C]cocaine were used to measure dopamine transporters in 20 never medicated adults with ADHD and 25 controls. Dopamine transporters were lower in left caudate (13%, p < 0.05) and in left nucleus accumbens (p < 0.005) in ADHD subjects than in controls. In putamen dopamine transporters did not differ between groups but were associated with scores of inattention (Conners Adult Attention Rating Scale) both in ADHD subjects (p < 0.005) and in controls (p < 0.005). Thus, for a given transporter level the scores for inattention were on average five times greater in ADHD subjects than in controls. These results do not corroborate increases in dopamine transporters in ADHD subjects and show that in some they are reduced. It also provides evidence that dopamine transporter levels modulate attention but suggest that additional pathology (e.g., prefrontal or cingulostriatal pathways, noradrenergic neurotransmission) is necessary to account for the large differences in inattention observed between controls and ADHD subjects.


Subject(s)
Attention Deficit Disorder with Hyperactivity/drug therapy , Attention Deficit Disorder with Hyperactivity/metabolism , Brain/drug effects , Brain/metabolism , Central Nervous System Stimulants/administration & dosage , Cocaine/pharmacokinetics , Dopamine Plasma Membrane Transport Proteins/metabolism , Adult , Attention Deficit Disorder with Hyperactivity/diagnostic imaging , Brain/diagnostic imaging , Carbon Radioisotopes/pharmacokinetics , Female , Humans , Male , Positron-Emission Tomography/methods , Radiopharmaceuticals/pharmacokinetics , Tissue Distribution/drug effects
12.
Proc Natl Acad Sci U S A ; 103(42): 15641-5, 2006 Oct 17.
Article in English | MEDLINE | ID: mdl-17023542

ABSTRACT

The neurobiological mechanisms underlying overeating in obesity are not understood. Here, we assessed the neurobiological responses to an Implantable Gastric Stimulator (IGS), which induces stomach expansion via electrical stimulation of the vagus nerve to identify the brain circuits responsible for its effects in decreasing food intake. Brain metabolism was measured with positron emission tomography and 2-deoxy-2[18F]fluoro-D-glucose in seven obese subjects who had the IGS implanted for 1-2 years. Brain metabolism was evaluated twice during activation (on) and during deactivation (off) of the IGS. The Three-Factor Eating Questionnaire was obtained to measure the behavioral components of eating (cognitive restraint, uncontrolled eating, and emotional eating). The largest difference was in the right hippocampus, where metabolism was 18% higher (P < 0.01) during the "on" than "off" condition, and these changes were associated with scores on "emotional eating," which was lower during the on than off condition and with "uncontrolled eating," which did not differ between conditions. Metabolism also was significantly higher in right anterior cerebellum, orbitofrontal cortex, and striatum during the on condition. These findings corroborate the role of the vagus nerve in regulating hippocampal activity and the importance of the hippocampus in modulating eating behaviors linked to emotional eating and lack of control. IGS-induced activation of regions previously shown to be involved in drug craving in addicted subjects (orbitofrontal cortex, hippocampus, cerebellum, and striatum) suggests that similar brain circuits underlie the enhanced motivational drive for food and drugs seen in obese and drug-addicted subjects, respectively.


Subject(s)
Brain , Electric Stimulation/methods , Gastric Mucosa/metabolism , Hippocampus/metabolism , Nerve Net/physiology , Obesity/metabolism , Reward , Adult , Brain/anatomy & histology , Brain/physiology , Eating , Emotions , Female , Humans , Male , Middle Aged , Statistics as Topic , Surveys and Questionnaires
13.
Arch Gen Psychiatry ; 63(9): 999-1008, 2006 Sep.
Article in English | MEDLINE | ID: mdl-16953002

ABSTRACT

CONTEXT: Predisposition to alcoholism is likely an interaction between genetic and environmental factors that confer vulnerability and protection. Alcoholic subjects have low levels of dopamine D(2) receptors in striatum, and increasing D(2) receptor levels in laboratory animals reduces alcohol consumption. OBJECTIVES: To test whether high levels of D(2) receptors may be protective against alcoholism and whether this is mediated by their modulation of activity in orbitofrontal cortex and cingulate gyrus (regions involved in salience attribution, emotional reactivity, and inhibitory control). DESIGN: Research (nonalcoholic subjects with a family history of alcoholism) and comparison (nonalcoholic subjects with a negative family history) sample. SETTING: Outpatient setting. PARTICIPANTS: Fifteen nonalcoholic subjects who had an alcoholic father and at least 2 other first- or second-degree relatives who were alcoholics (family-positive group) and 16 nonalcoholic controls with no family history of alcoholism (family-negative group). MAIN OUTCOME MEASURES: Results of positron emission tomography with raclopride C 11 to assess D(2) receptors and with fludeoxyglucose F 18 to assess brain glucose metabolism (marker of brain function). Personality measures were obtained with the Multidimensional Personality Questionnaire. RESULTS: Availability of D(2) receptors was significantly higher in caudate and ventral striatum in family-positive than family-negative subjects. In family-positive but not family-negative subjects, striatal D(2) receptors were associated with metabolism in anterior cingulate (Brodmann area 24/25) and orbitofrontal (Brodmann area 11) and prefrontal (Brodmann area 9/10) cortices, and with personality scores of positive emotionality. CONCLUSIONS: The higher-than-normal D(2) receptor availability in nonalcoholic members of alcoholic families supports the hypothesis that high levels of D(2) receptors may protect against alcoholism. The significant associations between D(2) receptors and metabolism in frontal regions involved with emotional reactivity and executive control suggest that high levels of D(2) receptors could protect against alcoholism by regulating circuits involved in inhibiting behavioral responses and in controlling emotions.


Subject(s)
Alcoholism/genetics , Alcoholism/metabolism , Brain/metabolism , Family , Receptors, Dopamine D2/genetics , Receptors, Dopamine D2/metabolism , Adult , Alcoholism/prevention & control , Ambulatory Care , Basal Ganglia/diagnostic imaging , Basal Ganglia/metabolism , Brain/diagnostic imaging , Caudate Nucleus/diagnostic imaging , Caudate Nucleus/metabolism , Emotions/physiology , Female , Fluorodeoxyglucose F18 , Frontal Lobe/diagnostic imaging , Frontal Lobe/metabolism , Genetic Predisposition to Disease , Glucose/metabolism , Gyrus Cinguli/diagnostic imaging , Gyrus Cinguli/metabolism , Humans , Male , Personality/classification , Personality Assessment , Positron-Emission Tomography , Raclopride
14.
Neuroimage ; 32(4): 1782-92, 2006 Oct 01.
Article in English | MEDLINE | ID: mdl-16757181

ABSTRACT

The response to drugs is affected by expectation, which in turn is sensitive to prior drug experiences. Here, we evaluate the effects of expectation on the responses to intravenous methylphenidate (0.5 mg/kg) in fifteen subjects who had minimal experience with stimulant drugs. We used positron emission tomography to measure brain glucose metabolism, which we used as a marker of brain function and tested them under four randomized conditions (1) expecting placebo and receiving placebo; (2) expecting placebo and receiving methylphenidate; (3) expecting methylphenidate and receiving methylphenidate; (4) expecting methylphenidate and receiving placebo. We show that methylphenidate-induced decreases in striatum were greater when subjects expected to receive methylphenidate than when they were not expecting it. We also show that the subjects' expectations affected their responses to placebo. That is, when subjects expected to receive methylphenidate but received placebo there were significant increases in ventral cingulate gyrus (BA 25) and nucleus accumbens (regions involved with emotional reactivity and reward). The effect was largest in subjects who, because of experimental randomization, had not experienced methylphenidate. Because subjects were told that methylphenidate could be experienced as pleasant, unpleasant or devoid of subjective effects these results suggest the involvement of the ventral cingulate and of the nucleus accumbens in processing expectation for "uncertain drug effects". Thus, the state of expectation needs to be considered as a variable modulating the reinforcing and therapeutic effects of drugs even in subjects who have no prior experience with the drug.


Subject(s)
Brain Chemistry/drug effects , Central Nervous System Stimulants/pharmacology , Methylphenidate/pharmacology , Substance-Related Disorders/psychology , Adult , Blood Pressure/drug effects , Blood Pressure/physiology , Brain/diagnostic imaging , Dopamine/physiology , Dopamine Plasma Membrane Transport Proteins/metabolism , Fluorodeoxyglucose F18 , Gyrus Cinguli/diagnostic imaging , Gyrus Cinguli/drug effects , Gyrus Cinguli/metabolism , Heart Rate/drug effects , Heart Rate/physiology , Humans , Male , Neostriatum/diagnostic imaging , Neostriatum/drug effects , Neostriatum/metabolism , Placebo Effect , Positron-Emission Tomography , Prefrontal Cortex/diagnostic imaging , Prefrontal Cortex/drug effects , Prefrontal Cortex/metabolism , Radiopharmaceuticals , Reward , Set, Psychology
15.
J Neurosci ; 26(24): 6583-8, 2006 Jun 14.
Article in English | MEDLINE | ID: mdl-16775146

ABSTRACT

The ability of drugs of abuse to increase dopamine in nucleus accumbens underlies their reinforcing effects. However, preclinical studies have shown that with repeated drug exposure neutral stimuli paired with the drug (conditioned stimuli) start to increase dopamine by themselves, which is an effect that could underlie drug-seeking behavior. Here we test whether dopamine increases occur to conditioned stimuli in human subjects addicted to cocaine and whether this is associated with drug craving. We tested eighteen cocaine-addicted subjects using positron emission tomography and [11C]raclopride (dopamine D2 receptor radioligand sensitive to competition with endogenous dopamine). We measured changes in dopamine by comparing the specific binding of [11C]raclopride when subjects watched a neutral video (nature scenes) versus when they watched a cocaine-cue video (scenes of subjects smoking cocaine). The specific binding of [11C]raclopride in dorsal (caudate and putamen) but not in ventral striatum (in which nucleus accumbens is located) was significantly reduced in the cocaine-cue condition and the magnitude of this reduction correlated with self-reports of craving. Moreover, subjects with the highest scores on measures of withdrawal symptoms and of addiction severity that have been shown to predict treatment outcomes, had the largest dopamine changes in dorsal striatum. This provides evidence that dopamine in the dorsal striatum (region implicated in habit learning and in action initiation) is involved with craving and is a fundamental component of addiction. Because craving is a key contributor to relapse, strategies aimed at inhibiting dopamine increases from conditioned responses are likely to be therapeutically beneficial in cocaine addiction.


Subject(s)
Cocaine-Related Disorders/psychology , Cocaine/administration & dosage , Corpus Striatum/drug effects , Cues , Dopamine Uptake Inhibitors/administration & dosage , Dopamine/metabolism , Adult , Brain Mapping , Cocaine-Related Disorders/metabolism , Corpus Striatum/diagnostic imaging , Corpus Striatum/metabolism , Dopamine Antagonists/pharmacokinetics , Female , Humans , Male , Middle Aged , Positron-Emission Tomography , Raclopride/pharmacokinetics , Reinforcement Schedule
16.
Proteomics ; 6(7): 2095-100, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16502467

ABSTRACT

Feature extraction or biomarker selection is a critical step in disease diagnosis and knowledge discovery based on protein MS. Many studies have discussed the classification methods applied in proteomics; however, few could be found to address feature extraction in detail. In this paper, we developed a systematic approach for the extraction of mass spectrum peak apex and peak area with special emphasis on noise filtration and peak calibration. Application to a head and neck cancer data generated at the Eastern Virginia Medical School [Wadsworth, J. T., Somers, K. D., Cazares, L. H., Malik, G. et al.., Clin. Cancer Res. 2004, 10, 1625-1632] revealed that the new feature extraction method would yield consistent and highly discriminatory biomarkers.


Subject(s)
Proteins/analysis , Proteomics/methods , Biomarkers, Tumor , Calibration , Computational Biology , Head and Neck Neoplasms/chemistry , Head and Neck Neoplasms/metabolism , Humans , Mass Spectrometry/methods , Mass Spectrometry/statistics & numerical data , Models, Chemical , Models, Statistical , Proteins/chemistry
17.
J Neurosci ; 25(15): 3932-9, 2005 Apr 13.
Article in English | MEDLINE | ID: mdl-15829645

ABSTRACT

Drugs of abuse are rewarding to addicted and nonaddicted subjects, but they trigger craving and compulsive intake only in addicted subjects. Here, we used positron emission tomography (PET) and [18F] deoxyglucose to compare the brain metabolic responses (marker of brain function) of cocaine-addicted subjects (n = 21) and controls (n = 15) to identify brain regions that are uniquely activated in addicted subjects by intravenous methylphenidate (a drug that cocaine-addicted subjects report to be similar to cocaine). In parallel, we also measured the changes in dopamine (DA) induced by intravenous methylphenidate (using PET and [11C] raclopride) in the striatum and in the thalamus. Metabolic responses between groups differed significantly only in the right medial orbital prefrontal cortex [Brodmann's area (BA) 25 and medial BA 11], where methylphenidate increased metabolism in addicted subjects but decreased metabolism in controls. These changes were associated in all subjects with increased "desire for methylphenidate" and in the addicted subjects with "cocaine craving." In addicted subjects, increases in BA 25 were also associated with mood elevation. Methylphenidate-induced increases in metabolism in the medial orbital prefrontal cortex were associated with its increase of DA in the thalamus but not in the striatum. These findings provide evidence that enhanced sensitivity of BA 25 (region involved with emotional reactivity) and BA 11 (region involved with salience attribution and motivation) in cocaine-addicted subjects may underlie the strong emotional response to the drug and the intense desire to procure it that results in craving and compulsive drug intake. It also suggests that the mesothalamic DA pathway may contribute to these processes.


Subject(s)
Behavior, Addictive/chemically induced , Central Nervous System Stimulants/administration & dosage , Cocaine-Related Disorders/metabolism , Methylphenidate/administration & dosage , Prefrontal Cortex/drug effects , Adult , Behavior, Addictive/diagnostic imaging , Behavior, Addictive/metabolism , Brain Mapping , Carbon Isotopes/pharmacokinetics , Cocaine-Related Disorders/psychology , Dopamine/metabolism , Dopamine Antagonists/pharmacokinetics , Fluorodeoxyglucose F18/pharmacokinetics , Functional Laterality , Humans , Male , Positron-Emission Tomography/methods , Prefrontal Cortex/diagnostic imaging , Raclopride/pharmacokinetics , Statistics as Topic
18.
Am J Psychiatry ; 161(2): 242-8, 2004 Feb.
Article in English | MEDLINE | ID: mdl-14754772

ABSTRACT

OBJECTIVE: Methamphetamine is a highly addictive drug of abuse that is neurotoxic to dopamine terminals. The authors recently reported that decreases in dopamine transporters (used as markers of dopamine terminals) in the striatum of methamphetamine abusers recover with protracted abstinence and that relative to comparison subjects, recently detoxified methamphetamine abusers have lower metabolism in the striatum and thalamus. In this study, the authors assessed whether metabolism recovers with protracted abstinence. METHOD: Brain glucose metabolism was measured with positron emission tomography and [18F]fluorodeoxyglucose in five methamphetamine abusers who were evaluated after both a short (<6 months) and protracted (12-17 months) abstinence interval, eight methamphetamine abusers tested only after protracted abstinence, and 11 comparison subjects who were not drug users. RESULTS: Significantly greater thalamic, but not striatal, metabolism was seen following protracted abstinence relative to metabolism assessed after a short abstinence interval, and this increase was associated with improved performance in motor and verbal memory tests. Relative to the comparison subjects, the methamphetamine abusers tested after protracted abstinence had lower metabolism in the striatum (most accentuated in the caudate and nucleus accumbens) but not in the thalamus. CONCLUSIONS: The persistent decreases in striatal metabolism in methamphetamine abusers could reflect long-lasting changes in dopamine cell activity, and decreases in the nucleus accumbens could account for the persistence of amotivation and anhedonia in detoxified methamphetamine abusers. The recovery of thalamic metabolism could reflect adaptation responses to compensate for the dopamine deficits, and the associated improvement in neuropsychological performance further indicates its functional significance. These results suggest that while protracted abstinence may reverse some of the methamphetamine-induced alterations in brain function, other deficits persist.


Subject(s)
Amphetamine-Related Disorders , Brain/metabolism , Brain/physiopathology , Dopamine/metabolism , Presynaptic Terminals/metabolism , Recovery of Function , Adaptation, Physiological , Adult , Amphetamine-Related Disorders/metabolism , Amphetamine-Related Disorders/physiopathology , Amphetamine-Related Disorders/prevention & control , Cognition Disorders/diagnosis , Corpus Striatum/metabolism , Corpus Striatum/physiopathology , Female , Fluorodeoxyglucose F18 , Humans , Male , Methamphetamine , Neuropsychological Tests , Radiopharmaceuticals , Thalamus/metabolism , Thalamus/physiopathology , Time Factors , Tomography, Emission-Computed
19.
Alcohol Alcohol ; 39(1): 53-8, 2004.
Article in English | MEDLINE | ID: mdl-14691075

ABSTRACT

AIMS AND METHODS: Acute alcohol administration induces marked decreases in glucose metabolism throughout the human brain. However, the relationship between alcohol's effects on brain metabolism and the behavioural changes that occur with intoxication are still unclear. Here we assessed this association using principal component analysis for dimension reduction and canonical correlations to gauge inter-class relationships. We also used canonical correlations in the polynomial space to assess for possible nonlinear relationships. RESULTS: After normalizing the regional measures to account for the large whole brain decreases observed with intoxication we show that the largest decreases occurred in occipital cortex and that there were relative increases in basal ganglia. Principal component analysis of the changes in the normalized measures revealed that 60% of the variance was accounted for by two factors; one that contrasted cerebellum versus frontal and anterior cingulate metabolism, and another that contrasted basal ganglia and insula. The square of the first factor was significantly correlated with the deterioration in cognitive performance. The second factor showed a significant linear correlation with self-reports of intoxication and with deterioration in cognitive and motor performance. CONCLUSIONS: These findings suggest that the contrasting effects of alcohol in basal ganglia versus the insula are involved in the perception of 'feeling drunk' and that its contrasting effects in cerebellum versus those in frontal and parietal cortices are involved in its motor incoordinating effects. On the other hand alcohol's impact on cognitive performance implicates a more complex pattern of brain effects that includes linear as well as non-linear associations.


Subject(s)
Alcoholic Intoxication/metabolism , Brain/metabolism , Cognition/drug effects , Adult , Behavioral Symptoms/metabolism , Central Nervous System Depressants/administration & dosage , Ethanol/administration & dosage , Female , Fluorodeoxyglucose F18 , Glucose/metabolism , Humans , Male , Motor Activity/drug effects , Radiopharmaceuticals , Tomography, Emission-Computed
20.
Proc Natl Acad Sci U S A ; 100(25): 14666-71, 2003 Dec 09.
Article in English | MEDLINE | ID: mdl-14657331

ABSTRACT

We propose a comprehensive pattern recognition procedure that will achieve best discrimination between two or more sets of subjects with data in the same coordinate system. Applying the procedure to MS data of proteomic analysis of serum from ovarian cancer patients and serum from cancer-free individuals in the Food and Drug Administration/National Cancer Institute Clinical Proteomics Database, we have achieved perfect discrimination (100% sensitivity, 100% specificity) of patients with ovarian cancer, including early-stage disease, from normal controls for two independent sets of data. Our procedure identifies the best subset of proteomic biomarkers for optimal discrimination between the groups and appears to have higher discriminatory power than other methods reported to date. For large-scale screening for diseases of relatively low prevalence such as ovarian cancer, almost perfect specificity and sensitivity of the detection system is critical to avoid unmanageably high numbers of false-positive cases.


Subject(s)
Biomarkers, Tumor/blood , Mass Spectrometry/methods , Neoplasms/diagnosis , Neoplasms/genetics , Algorithms , Databases as Topic , Female , Humans , Internet , Ovarian Neoplasms/metabolism , Predictive Value of Tests , Proteome , Sensitivity and Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...